Irkutsk, Irkutsk region, Russian Federation
Irkutsk, Irkutsk region, Russian Federation
Irkutsk, Irkutsk region, Russian Federation
Cel'yu issledovaniya stala ocenka intensivnosti processov lipoperoksidacii u beremennyh zhenschin s hronicheskimi virusnymi gepatitami. Ispol'zovalis' sovremennye spektrofotometricheskie i statisticheskie metody. Ustanovleno, chto v plazme krovi u pacientok gruppy issledovaniya znachimo povysheny urovni promezhutochnyh i konechnyh produktov lipoperoksidacii, po sravneniyu s gruppoy kontrolya, chto svidetel'stvuet o nalichii okislitel'nogo stressa u bol'nyh virusnymi gepatitami. Issledovanie pokazateley lipoperoksidacii yavlyaetsya informativnym metodom pri korrekcii zabolevaniya.
gepatit, perekisnoe okislenie lipidov, beremennye
1. Kolesnikova LI, Darenskaya MA, Dolgikh VV, Shenin VA, Osipova EV, Grebyonkina LA, Dolgikh MI, Mandzyak TV (2010). Specific features of the processes of lipid peroxidation antioxidant protection in various ethnic groups of East Siberia [Osobennosti protsessov perekisnogo okisleniya lipidov-antioksidantnoy zashchity v razlichnykh etnicheskikh gruppakh Vostochnoy Sibiri]. Ekologiya cheloveka, (2), 26-29.
2. Kudashkina EA (2012). The original approach to the treatment of viral hepatitis B and C [Original’nyy podkhod k terapii pri virusnykh gepatitakh B i C]. Innovatsii v nauke, (6), 139-142.
3. Ladygin KV, Boldyrev AV, Stativko OA, Avdeeva IV (2014). Epidemiological aspects of chronic hepatitis in HIV-infected women during their pregnancy [Epidemiologicheskie aspekty khronicheskikh gepatitov u VICh-infitsirovannykh zhenshchin vo vremya ikh beremennosti]. Nauchnye vedomosti. Seriya Meditsina. Farmatsiya, 25 (4), 5-10.
4. Reneva LV, Volkova LV, Kazyanin AV (2013). Plasma donors’ post-vaccination immunity to hepatitis [Postvaktsinal’nyy immunitet k gepatitu u donorov plazmy]. Vestnik Ural’skoy meditsinskoy akademii nauk, (1), 73-76.
5. Shekhtman MM (2004). Chronic hepatitis and liver cirrhosis in pregnant women [Khronicheskiy gepatit i tsirroz pecheni u beremennykh]. Ginekologiya, (6), 18-21.
6. Yushchuk ND, Znoyko OO, Dudina KR, Belyi PA (2014). The problem of hepatitis C in the Russian Federation [Problema virusnogo gepatita C v Rossiyskoy Federatsii]. Terapevticheskiy arkhiv, 86 (10), 77-81.
7. Bairova TA, Kolesnikov SI, Kolesnikova LI, Pervushina OA, Darenskaya MA, Grebenkina LA (2014). Lipid peroxidation and mitochondrial superoxide dismutase-2 gene in adolescents with essential hypertension. Bulletin of Experimental Biology and Medicine, 158 (2), 181-184.
8. Chen CJ, Yang HI, Iloeje UH (2009). Hepatitis B virus DNA levels and outcomes in chronic hepatitis B Hepatitis B virus DNA levels and outcomes in chronic hepatitis B. Hepatology, 49, 72-84.
9. Dienstag JL (2008). Hepatitis B virus infection. The New Engl. J. Med., 359 (14), 1486-1500.
10. Kolesnikova L, Darenskaya M, Grebenkina L, Timofeeva E, Leshenko O, Semenova N, Kurashova N, Vanteeva O (2014) Oxidative stress parameters in women with HIV and HIV/hepatitis B and/or C co-infection. Journal of AIDS and Clinical Research, 5 (11), 5-11.
11. Kolesnikova LI, Darenskaya MA, Semenova NV, Grebenkina LA, Suturina LV, Dolgikh MI, Gnusina SV (2015). Lipid peroxidation and antioxidant protection in girls with type 1 diabetes mellitus during reproductive system development. Medicina (Kaunas, Lithuania), 51 (2), 107-111.
12. Kolesnikova LI, Kolesnikov SI, Darenskaya MA, Grebenkina LA, Gnusina SV (2015). Antioxidant status of two ethnic groups’ adolescent girls with diabetes mellitus type 1. Diabetes technology and therapeutics, 17 (1), 421-422.
13. Kolesnikova LI, Madaeva IM, Semenova NV, Vlasov BY, Grebenkina LA, Darenskaya MA, Dolgikh MI (2013). Antioxidant potential of the blood in men with obstructive sleep breathing disorders. Bulletin of Experimental Biology and Medicine, 154 (6), 731-733.
